Skip to main content

Frontiers Clinical and Translational Research Pilot Study

The Dr. Lauren S. Aaronson Frontiers Clinical and Translational Research Pilot Study Program provides support to grow interdisciplinary, investigator-initiated clinical and translational research across a broad range of scientific disciplines.

To accomplish the NCATS goal "to get more treatments to more patients more quickly", the Frontiers Pilot Study Program promotes clinical and translational research (CTR) that will compete successfully for extramural funding. The Frontiers Pilot Study Program places special emphasis on research targeting the special needs of vulnerable, rural, rare and marginalized groups who historically have not been involved in CTR. We anticipate four projects will be selected for funding: two for general CTR projects and two for COVID-19 related studies.

Click here to view the 2021-2022 Frontiers Pilot Study program Letter of Intent RFA [PDF]

Key Dates:

  • Posted Date: October 21, 2020
  • LOIs Due: November 14, 2020
  • Notification to Applicants: First week in December, 2020
  • Full Proposals Due: March 1, 2021
  • Project Start Date: July 1, 2021 (pending NCATS approval)

Eligibility

Investigators from all Frontiers institutions are eligible to apply to the Dr. Lauren S. Aaronson Frontiers Clinical and Translational Research Pilot Study program if they are eligible to apply for NIH awards as a principal investigator. One proposal will be accepted per applicant; applicants may collaborate on other proposals.

It is expected that all research supported by Frontiers pilot project awards will result in one or more publications in peer-reviewed journals and will provide critical preliminary data to support extramural applications.

All questions regarding the Dr. Lauren S. Aaronson Frontiers Clinical and Translational Research Pilot Study should be directed to frontiers-info@kumc.edu or 913-588-6290.

Last modified: Jan 07, 2021
ID=x31852